Overview

The Gene Technology Act 2000, enacted by the Parliament of Australia, addresses the regulation of genetically modified organisms to ensure protection of human health and the environment. The Act was introduced to address the need for a comprehensive regulatory framework that could manage the risks associated with the development and use of genetically modified organisms in Australia. The policy objective of the Act is to provide a regulatory system that allows for the safe development of biotechnology while also protecting the public and the environment from potential risks. The Gene Technology Regulator, as part of the Office of the Gene Technology Regulator, is responsible for assessing applications such as the proposed field trial of genetically modified safflower by Miruku Australia Pty Ltd, ensuring that all activities comply with the objectives and provisions of the Act.

Scope and Application

The Gene Technology Act 2000, as amended, applies to the proposed field trial of genetically modified safflower by Miruku Australia Pty Ltd. This Act governs the regulation of genetically modified organisms and products in Australia, including the assessment and licensing of field trials such as this one. The Act applies to the entities involved in the trial, the genetically modified organisms being trialled, and the specific conduct and transactions related to the trial. The jurisdictional reach of the Act is national, with the Gene Technology Regulator acting on behalf of the Commonwealth, although the field trial sites are geographically distributed across New South Wales, Victoria, Western Australia, and South Australia. The Act does not apply to the plants grown in this trial as they are not intended for human food or animal feed. The application for the field trial is subject to public consultation, with submissions being invited regarding the protection of human health, safety, and the environment. Submissions should be made in reference to DIR 211 and must be received by 1 May 2025. The Act allows for the extension or restriction of its application through subordinate instruments, which may further detail the specific requirements and conditions for such field trials.

Key Provisions

The primary operative sections of this legislation (Gazette, 2025) pertain to the assessment of an application by Miruku Australia Pty Ltd for a field trial of genetically modified safflower (DIR 211). Section 2 outlines the specifics of the proposed trial, including the trial's geographical spread across NSW, Vic, WA, and SA, and the planned increase in planting area from 1 hectare in 2025 to a maximum of 981 hectares by 2029. The safflower in question is genetically modified for dairy protein production and altered fat composition, with the stipulation that these plants will not be used for human food or animal feed (Section 3). The obligations and requirements imposed by the Act are detailed in Section 4, which mandates the preparation of a Risk Assessment and Risk Management Plan (RARMP) by the Gene Technology Regulator. This document must consider the protection of human health and safety and the environment, which is a central focus of the Regulator's assessment of the application. Section 5 invites written submissions from the public, with a specific call for comments on the RARMP and related information. This participatory approach is aimed at ensuring that a broad range of perspectives is considered before a decision on the licence is made. Submissions must reference DIR 211 and are to be received by 1 May 2025, as stated in Section 6. The Act does not explicitly detail offences, penalties, or specific consequences for breaches within the text provided. However, the overarching legal framework governing gene technology in Australia does include provisions for non-compliance. Breaches of the Act can lead to civil or criminal penalties, which may include fines and imprisonment, depending on the severity and nature of the breach. The maximum penalties are not detailed in the provided text but can be found in the broader legislative context governing gene technology regulation in Australia.